Aspen Aerogels (NYSE:ASPN) Stock Crosses Below 200-Day Moving Average - Here's Why

Key Points

• Aspen Aerogels shares crossed below their 200‑day moving average of $4.44, trading as low as $3.32 and last at $3.6950 on volume of about 1.37 million, signaling renewed technical weakness.
• The company missed quarterly expectations with EPS of ($0.34) and revenue of $41.34M (down 66.4% year‑over‑year), reported negative margins, and set Q1 2026 guidance of -0.280 to -0.240 EPS.
• Analysts are mixed but cautious — MarketBeat shows a consensus "Hold" with a $4.25 target after several price‑target cuts and rating changes, while institutional investors own roughly 97.6% of the stock.

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.44 and traded as low as $3.32. Aspen Aerogels shares last traded at $3.6950, with a volume of 1,373,521 shares traded.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Zacks Research raised Aspen Aerogels from a "strong sell" rating to a "hold" rating in a research report on Thursday, January 15th. TD Cowen lowered their price target on Aspen Aerogels from $7.00 to $6.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Weiss Ratings restated a "sell (d-)" rating on shares of Aspen Aerogels in a report on Friday, March 27th. Barclays reduced their price objective on Aspen Aerogels from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Thursday, March 5th. Finally, Roth Mkm decreased their target price on Aspen Aerogels from $6.00 to $3.00 and set a "buy" rating for the company in a report on Thursday, February 26th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $4.25.

Aspen Aerogels Trading Up 0.1%

The company has a current ratio of 3.90, a quick ratio of 3.29 and a debt-to-equity ratio of 0.34. The business has a 50 day simple moving average of $3.38 and a two-hundred day simple moving average of $4.44. The stock has a market cap of $306.06 million, a price-to-earnings ratio of -0.78 and a beta of 2.90.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Wednesday, February 25th. The construction company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The business had revenue of $41.34 million for the quarter, compared to analysts' expectations of $44.25 million. Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.91%. The business's quarterly revenue was down 66.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.14 earnings per share. Aspen Aerogels has set its Q1 2026 guidance at -0.280--0.240 EPS. As a group, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of the stock. Raymond James Financial Inc. increased its holdings in Aspen Aerogels by 6.8% in the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company's stock valued at $157,000 after buying an additional 1,687 shares during the last quarter. Legal & General Group Plc grew its position in shares of Aspen Aerogels by 3.6% in the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company's stock worth $397,000 after acquiring an additional 2,324 shares in the last quarter. Osaic Holdings Inc. grew its position in shares of Aspen Aerogels by 29.1% in the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company's stock worth $63,000 after acquiring an additional 2,390 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company's stock valued at $146,000 after acquiring an additional 2,656 shares during the last quarter. Finally, Deutsche Bank AG raised its position in shares of Aspen Aerogels by 1.3% during the 4th quarter. Deutsche Bank AG now owns 223,093 shares of the construction company's stock valued at $631,000 after acquiring an additional 2,880 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.